18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis
Top Cited Papers
- 1 February 2004
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 31 (2), 179-189
- https://doi.org/10.1016/j.nucmedbio.2003.10.002
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Direct electrophilic radiofluorination of a cyclic RGD peptide for in vivo αvβ3 integrin related tumor imagingNuclear Medicine and Biology, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Comparison of a Monomeric and Dimeric Radiolabeled RGD-Peptide for Tumor TargetingCancer Biotherapy & Radiopharmaceuticals, 2002
- In Vitro and in Vivo Evaluation of a Technetium-99m-Labeled Cyclic RGD Peptide as a Specific Marker of αVβ3 Integrin for Tumor ImagingBioconjugate Chemistry, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- N-Methylated Cyclic RGD Peptides as Highly Active and Selective αVβ3Integrin AntagonistsJournal of Medicinal Chemistry, 1999
- Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv IntegrinsCell, 1998
- Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991Journal of Neurosurgery, 1998
- Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: A high yield synthesis of 6-[18F]fluoro-l-dopaInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992
- Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoateInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992